Company Vision

MediVision Medical Imaging Ltd. is a leader in manufacturing innovative, clinically advanced digital imaging equipment for the eye care community. Our products also deliver worldwide connectivity, networking, archiving, and professional services through a strategic alliance with Agfa, a global leader in Image Management and Picture Archiving and Communications Systems (PACS).

MediVision is dedicated to revolutionizing imaging technology through the development and marketing of cutting-edge, proprietary digital imaging systems for a full range of applications in Ophthalmology. MediVision is pledged to providing digital solutions for visual ophthalmic products that significantly enhance diagnostic capability and accuracy as well as a variety of Information Technology solutions for the ophthalmic professionals.

A History of Innovation

MediVision was established in 1993 by a core group of experienced marketing and computer and electronics engineers with extensive experience in medical imaging and other high-tech fields.

Based on the technical platform, vast experience, and the accumulated know-how of a highly-trained staff of engineers from a wide variety of interdisciplinary disciplines, MediVision develops and manufactures high resolution digital imaging solutions for ophthalmology as well as advanced Information Technology central database solutions and Internet capabilities.

MediVision Medical Imaging Ltd. is traded on the EURO.NM stock exchange in Belgium (EURO.NM: MEDV). In September 2000, it acquired a majority interest in Ophthalmic Imaging Systems Inc. (NASDAQ: OISI.OB), a long time player and a pioneer vendor of digital imaging systems for various ophthalmic applications. Ophthalmic Imaging Systems (OIS) is based in Sacramento, California, and is considered to be the market leader in North America.

As of October 2001 MediVision is acting under a co-development and co-marketing agreement with Agfa.

Technologies

At the core of MediVision's product line is the unprecedented synergy of its core know-how:
State-of-the-art imaging systems—based on the latest Windows 2000/XP operating system and computer technology. The proprietary real-time processing hardware and software feature a variety of high performance CCD cameras with analog and digital image acquisition capabilities, multiple images display channels, and real-time image processing and filtering capabilities.

Advanced software solutions—the unique user-friendly operating software provides for simplification of the operation, advanced image processing, as well as networking and archiving tools. Thus, thanks to the system's interconnectivity and modularity, Intranet applications with hospitals is available in addition to broader Internet applications.

MediVision's ophthalmic line of products provides total digital solutions for a range of visual products, significantly enhancing imaging capability and providing its user with unprecedented diagnostic tools. MediVision solutions entail Internet communication advantages facilitating consultation and usage of information even with remote workstations. The possibility to provide such a complete digital solution to the ophthalmic community is unparalleled by any other company in the market.

Sales

MediVision markets and sells its products in North America through its American subsidiary, OIS (Ophthalmic Imaging Systems Inc.), which has a nationwide coverage of the US with its own sales, marketing, sales support, and technical-support team.

Marketing and Sales activities in Germany are performed by CCS-Pawloski, MediVision German subsidiary, and in Belgium-France by MediVision's Belgian branch.

Beyond the these, international sales and marketing activities are strategically implemented through a worldwide network of distributors. All of MediVision's distributors are carefully selected, trained, and equipped to provide leading marketing and technical support.

Company Employees

MediVision currently has more than 70 employees, the majority of which are based in North America, with research and development based both in Israel and US.